<DOC>
	<DOC>NCT02023190</DOC>
	<brief_summary>Liver transplant is the goal treatment for every patient with end-stage chronic liver disease. Quality of life improves after transplant because the main complications of end-stage liver disease disappear, but due to immunosuppression other alterations appear such as metabolic alterations, weight gain, among others. Body composition and nutritional status can be affected do to post-transplant pharmacologic therapy.</brief_summary>
	<brief_title>Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation</brief_title>
	<detailed_description>Body composition and nutritional status can be affected due to post-transplant pharmacologic therapy. This is a prospective cohort study, patients from liver transplant waiting list will be assessed, pre and post-transplant measures of body composition and nutritional status will be obtained.</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Liver cirrhosis (any etiology) Enrolled in waiting list for tliver transplant Hepatocellular carcinoma Chronic renal failure Congestive cardiac failure Extremity amputation Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>liver cirrhosis</keyword>
	<keyword>liver transplant</keyword>
	<keyword>nutritional status</keyword>
	<keyword>bioelectrical impedance vector analysis</keyword>
</DOC>